# Development and Validation of a Triplex RT-qPCR Assay for Rapid Clinical Diagnosis and Serotyping of Feline Infectious Peritonitis Virus

**Authors:** Ruilong Xiao, Yanhe Chen, Ying Huang, Chunhao Tao, Xinxin Jin, Yingjia Gu, Weifeng Yuan, Wenjin Song, Zhen Wang, Huanrong Li, Hong Jia

PMC · DOI: 10.3390/ijms27052204 · International Journal of Molecular Sciences · 2026-02-26

## TL;DR

A new RT-qPCR test was developed to quickly detect and classify FIP virus in cats, aiding faster and more accurate diagnosis.

## Contribution

A novel triplex RT-qPCR assay was developed for simultaneous detection and serotyping of FIPV with high sensitivity and specificity.

## Key findings

- The assay detected FIPV with a limit of 0.5 copies/µL and showed high amplification efficiency (97.39–109.97%).
- Clinical validation showed a 21.63% FIPV positivity rate, with serotype II more prevalent than serotype I.
- The assay demonstrated no cross-reactivity with other feline pathogens and high intra-assay repeatability.

## Abstract

Feline infectious peritonitis (FIP) is a highly lethal disease caused by feline infectious peritonitis virus (FIPV), which poses significant diagnostic challenges in clinical practice. FIPV is divided into two serotypes (serotype I and serotype II) based on distinct serological responses driven by substantial sequence divergence in the spike (S) protein. Serotype I predominates in Europe and North America, whereas serotype II is more common in Asia. In this study, we developed a triplex reverse transcription quantitative PCR (RT-qPCR) assay for simultaneous detection and serotyping of FIPV. Primers and TaqMan probes were designed to target the conserved nucleocapsid (N) gene and serotype-specific regions within the S gene. After systematic optimization of reaction conditions, the final assay employed an annealing temperature of 64 °C and optimized primer–probe concentrations. The assay exhibited excellent linearity (R2 > 0.99 for all targets), with amplification efficiencies ranging from 97.39% to 109.97%. No cross-reactivity was observed with other common feline pathogens, confirming high specificity. The limit of detection was as low as 0.5 copies/µL, and intra-assay repeatability showed coefficients of variation below 2.1%. Clinical validation using 63 feline samples revealed an overall FIPV positivity rate of 21.63%, with serotype II (17.46%) markedly more prevalent than serotype I (3.17%). Collectively, this triplex RT-qPCR assay demonstrates high sensitivity, exceptional specificity, and robust reproducibility, making it a valuable tool for rapid clinical diagnosis through the simultaneous detection of feline coronavirus (FCoV) and serotyping of FIPV.

## Linked entities

- **Genes:** S (Star) [NCBI Gene 33281], N (Notch) [NCBI Gene 31293]
- **Diseases:** Feline infectious peritonitis (MONDO:0025491), FIP (MONDO:0025491)

## Full-text entities

- **Diseases:** FIP (MESH:D016766)
- **Species:** Feline infectious peritonitis virus (no rank) [taxon 11135], Feline coronavirus (no rank) [taxon 12663]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12984934/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12984934/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12984934/full.md

---
Source: https://tomesphere.com/paper/PMC12984934